Mesirow Financial Investment Management’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Hold
30,000
﹤0.01% 529
2026
Q1
$48.9K Buy
+30,000
New +$51.2K ﹤0.01% 512
2025
Q4
Sell
-30,000
Closed -$72.3K 535
2025
Q3
$72.3K Hold
30,000
﹤0.01% 545
2025
Q2
$68.1K Hold
30,000
﹤0.01% 524
2025
Q1
$80.7K Hold
30,000
﹤0.01% 568
2024
Q4
$78.9K Hold
30,000
﹤0.01% 576
2024
Q3
$80.4K Hold
30,000
﹤0.01% 572
2024
Q2
$74.9K Hold
30,000
﹤0.01% 491
2024
Q1
$71.1K Hold
30,000
﹤0.01% 503
2023
Q4
$84.3K Buy
+30,000
New +$86.4K ﹤0.01% 540

Other funds holding NSPR

Mesirow Financial Investment Management's NSPR Position: Q2 2026 in Review

Mesirow Financial Investment Management held its InspireMD (NSPR) position steady in Q2 2026 at 30,000 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #529.

Mesirow Financial Investment Management first reported a position in NSPR in Q4 2023 and has held it in 10 quarters since. The position peaked at $84.3K in Q4 2023. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Mesirow Financial Investment Management held 30,000 shares of InspireMD worth $21K as of Q2 2026.
  • Mesirow Financial Investment Management left its InspireMD share count unchanged in Q2 2026.
  • InspireMD made up ﹤0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #529 holding.
  • Mesirow Financial Investment Management first reported a position in InspireMD in Q4 2023 and has held it in 10 quarters since.
  • Mesirow Financial Investment Management's InspireMD position peaked at $84.3K in Q4 2023.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.